141 related articles for article (PubMed ID: 12955292)
1. Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective.
Fenton WS; Stover EL; Insel TR
Psychopharmacology (Berl); 2003 Sep; 169(3-4):365-6. PubMed ID: 12955292
[No Abstract] [Full Text] [Related]
2. Medicine. What are the right targets for psychopharmacology?
Hyman SE; Fenton WS
Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001
[No Abstract] [Full Text] [Related]
3. The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia.
Marder SR
Dialogues Clin Neurosci; 2006; 8(1):109-13. PubMed ID: 16640121
[TBL] [Abstract][Full Text] [Related]
4. A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project.
Bromley E
Schizophr Bull; 2005 Oct; 31(4):954-61. PubMed ID: 16166607
[TBL] [Abstract][Full Text] [Related]
5. The NIMH perspective: next steps in schizophrenia research.
Hyman SE
Biol Psychiatry; 2000 Jan; 47(1):1-7. PubMed ID: 10650443
[No Abstract] [Full Text] [Related]
6. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.
Marder SR; Fenton W
Schizophr Res; 2004 Dec; 72(1):5-9. PubMed ID: 15531402
[TBL] [Abstract][Full Text] [Related]
7. Cognitive neuroscience and schizophrenia: translational research in need of a translator.
Cohen JD; Insel TR
Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873
[No Abstract] [Full Text] [Related]
8. Wayne Fenton and recovery.
Bellack AS; Frese FJ
Schizophr Bull; 2007 Sep; 33(5):1160-1. PubMed ID: 17567625
[No Abstract] [Full Text] [Related]
9. Wayne Fenton's impact on industry.
Breier A; Alphs L; Binneman B
Schizophr Bull; 2007 Sep; 33(5):1154-5. PubMed ID: 17562696
[No Abstract] [Full Text] [Related]
10. Stimulating the development of drug treatments to improve cognition in schizophrenia.
Green MF
Annu Rev Clin Psychol; 2007; 3():159-80. PubMed ID: 17716052
[TBL] [Abstract][Full Text] [Related]
11. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.
Green MF; Nuechterlein KH; Gold JM; Barch DM; Cohen J; Essock S; Fenton WS; Frese F; Goldberg TE; Heaton RK; Keefe RS; Kern RS; Kraemer H; Stover E; Weinberger DR; Zalcman S; Marder SR
Biol Psychiatry; 2004 Sep; 56(5):301-7. PubMed ID: 15336511
[TBL] [Abstract][Full Text] [Related]
12. Drug initiatives to improve cognitive function.
Marder SR
J Clin Psychiatry; 2006; 67 Suppl 9():31-5; discussion 36-42. PubMed ID: 16965187
[TBL] [Abstract][Full Text] [Related]
13. PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP.
GUTTMACHER MS
Arch Gen Psychiatry; 1964 Mar; 10():246-61. PubMed ID: 14089354
[No Abstract] [Full Text] [Related]
14. New paradigms for treatment development.
Stover EL; Brady L; Marder SR
Schizophr Bull; 2007 Sep; 33(5):1093-9. PubMed ID: 17673495
[TBL] [Abstract][Full Text] [Related]
15. Translating discoveries into medicine: psychiatric drug development in 2011.
Brady LS; Insel TR
Neuropsychopharmacology; 2012 Jan; 37(1):281-3. PubMed ID: 22157856
[No Abstract] [Full Text] [Related]
16. Wayne Fenton: impact on food and drug administration.
Laughren T
Schizophr Bull; 2007 Sep; 33(5):1153. PubMed ID: 17578891
[No Abstract] [Full Text] [Related]
17. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
Green MF; Nuechterlein KH; Kern RS; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Seidman LJ; Stover E; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):221-8. PubMed ID: 18172017
[TBL] [Abstract][Full Text] [Related]
18. Current status and prospects for NIMH research training support in clinical experimental psychopharmacology.
Lash L
Psychopharmacol Bull; 1988; 24(2):282-4. PubMed ID: 3212162
[No Abstract] [Full Text] [Related]
19. NIMH Preclinical/Clinical Therapeutics Research meeting--preclinical drug discovery session.
Douglas SD
J Neuroimmune Pharmacol; 2007 Mar; 2(1):5-7. PubMed ID: 18040819
[No Abstract] [Full Text] [Related]
20. Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative.
Marder SR; Fenton W; Youens K
Am J Psychiatry; 2004 Jan; 161(1):25. PubMed ID: 14702244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
